Table 2 Patients (%) reporting adverse events (AEs).
Type of AEs | No. (% of total n = 14) |
|---|---|
Any AEs | 1 (7) |
Serious AE (grade ≥ 3) | 3 (21) |
AEs leading to discontinuation | 1 (7) |
AEs leading to dose reduction | 0 (0) |
Death due to combination therapy | 0 (0) |
Death due to disease progression | 9 (64) |
